No Nephrologist Referral Required
This patient with an eGFR of 60 mL/min/1.73 m² or higher, normal liver enzymes, normal CBC, and currently on methotrexate does not require referral to a nephrologist at this time.
Rationale Based on Guidelines
The threshold for nephrology referral is clearly established at eGFR <30 mL/min/1.73 m² across multiple authoritative guidelines 1, 2, 1, 3. Your patient with eGFR ≥60 mL/min/1.73 m² falls well above this threshold and represents either normal kidney function (G1: eGFR ≥90) or mildly decreased kidney function (G2: eGFR 60-89).
The Canadian Society of Nephrology explicitly states that patients with less significantly decreased eGFRs can often be managed in primary care, office nephrology practice, or by internists/endocrinologists depending on the clinical situation 1. The 2015 Canadian commentary emphasizes that formal nephrology referral may not be necessary if findings are stable and isolated 1.
Methotrexate Safety Considerations
From a methotrexate safety perspective, this patient is in a safe zone:
- Methotrexate dosing is safe at normal doses when eGFR is >60 mL/min/1.73 m² 4, 5
- The FDA label and British Association of Dermatologists guidelines recommend dose reduction only when GFR falls to 20-50 mL/min/1.73 m², and avoidance when GFR <20 mL/min/1.73 m² 4, 5
- With normal liver enzymes and normal CBC, there are no current signs of methotrexate toxicity requiring specialist input
Monitoring Strategy Instead of Referral
Rather than nephrology referral, this patient requires:
- Regular monitoring of kidney function every 1-2 months while on methotrexate 4
- Continued monitoring of CBC and liver function tests at the same intervals
- Reassessment for referral if:
- eGFR drops below 30 mL/min/1.73 m² 1, 2, 1, 3
- Abrupt sustained decline in eGFR >20% after excluding reversible causes 1
- Development of significant proteinuria (ACR ≥60 mg/mmol or protein excretion >1 g/day) 1
- Persistent abnormalities in liver function tests or blood counts
- Unexplained hematuria with RBC casts 1
Key Clinical Pitfall to Avoid
The most important pitfall is failing to monitor kidney function regularly in patients on methotrexate. While this patient doesn't need a nephrologist now, methotrexate can cause nephrotoxicity 6, 7, and reduced renal function leads to methotrexate accumulation and increased toxicity risk 5, 6. Ensure creatinine and eGFR are checked every 1-2 months, and be vigilant for any decline in kidney function that would trigger the need for dose adjustment or specialist referral.